KAPPEL, BEN ARPAD

KAPPEL, BEN ARPAD  

Dipartimento di Medicina dei sistemi  

Mostra records
Risultati 1 - 5 di 5 (tempo di esecuzione: 0.008 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
13-mar-2020 Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment Kappel, Ba; De Angelis, L; Heiser, M; Ballanti, M; Stoehr, R; Goettsch, C; Mavilio, M; Artati, A; Paoluzi, Oa; Adamski, J; Mingrone, G; Staels, B; Burcelin, R; Monteleone, G; Menghini, R; Marx, N; Federici, M Articolo su rivista
1-gen-2016 Erratum: A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction (Cell Reports (2016) 16(3) (731–743) (S2211124716307677) (10.1016/j.celrep.2016.06.027)) Mavilio, M; Marchetti, V; Fabrizi, M; Stöhr, R; Marino, A; Casagrande, V; Fiorentino, L; Cardellini, M; Kappel, Ba; Monteleone, I; Garret, C; Mauriello, A; Monteleone, G; Farcomeni, A; Burcelin, R; Menghini, R; Federici, M Articolo su rivista
1-gen-2021 Human and mouse non-targeted metabolomics identify 1,5-anhydroglucitol as SGLT2-dependent glycemic marker Kappel, Ba; Moellmann, J; Thiele, K; Rau, M; Artati, A; Adamski, J; Ghesquiere, B; Schuett, K; Romeo, F; Stoehr, R; Marx, N; Federici, M; Lehrke, M Articolo su rivista
1-gen-2022 Non-targeted metabolomics identify polyamine metabolite acisoga as novel biomarker for reduced left ventricular function Puetz, A; Artati, A; Adamski, J; Schuett, K; Romeo, F; Stoehr, R; Marx, N; Federici, M; Lehrke, M; Kappel, Ba Articolo su rivista
1-gen-2017 The PDE4 inhibitor roflumilast reduces weight gain by increasing energy expenditure and leads to improved glucose metabolism Möllmann, J; Kahles, F; Lebherz, C; Kappel, Ba; Baeck, C; Tacke, F; Werner, C; Federici, M; Marx, N; Lehrke, M Articolo su rivista